Early detection of wet AMD with ForeseeHome® is an important step towards protecting your eyesight. Your eye doctor has submitted a ForeseeHome® prescription for you to Notal Vision, the company that makes the device and will monitor your vision.

To begin your enrollment in the ForeseeHome® AMD Monitoring Program, complete and submit the following form. A customer service representative from Notal Vision will contact you by phone in within 48 hours to complete your enrollment.

If you have any questions or need assistance completing the form, Customer Service representatives are available Monday – Friday (8 AM – 8 PM EST) at 1-888-910-2020.

  • Personal
  • Insurance Card
  • Preview

Personal Details

English Spanish French

Yes No

Note: If you don't have email address, you can contact us directly on 1-888-910-2020.

Insurance Plans

Upload Image Fill in
Yes No

Yes No
Upload Image Fill in


Personal Details
Insurance Details

Primary Insurance Plan

Secondary Insurance Plan

Enter Physician Details
Subscribe me to your mailing list

By checking the box above, you agree to receive product and disease-state information from Notal Vision and its affiliates, service providers, and co-promotion partners.

FDA Indication for Use

The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration, as an aid in monitoring progression of disease factors causing metamorphopsia including but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.

The ForeseeHome AMD Monitoring Program is only available by physician order and is intended to be used as an addition to regular eye exams.

The ForeseeHome AMD Monitoring Program is covered by Medicare, subject to its coverage requirements for the test, to assess patients with dry AMD who are at risk of developing wet AMD.